Skip to main content
Guerbet logo

Guerbet — Investor Relations & Filings

Ticker · GBT ISIN · FR0000032526 LEI · 969500WV1U1WQ059L135 PA Manufacturing
Open in API
Filings indexed 623 across all filing types
Latest filing 2011-04-27 Earnings Release
Country FR France
Listing PA GBT

About Guerbet

https://www.guerbet.com

Guerbet is a global specialist in medical imaging, offering a comprehensive range of solutions and services for diagnostic and interventional procedures. The company develops and manufactures contrast media, medical devices such as injectors, and related software for X-ray, Magnetic Resonance Imaging (MRI), and Interventional Imaging. With a history of innovation dating back to 1926, Guerbet focuses on providing healthcare professionals with tools to enhance diagnostic accuracy and improve patient care. Its portfolio is designed to support a wide array of clinical applications, from initial diagnosis to treatment monitoring.

Recent filings

Filing Released Lang Actions
Guerbet - 2011 first-quarter sales
Earnings Release Classification · 99% confidence The document is explicitly titled "PRESS RELEASE" and presents key financial highlights for a specific, short reporting period: "2011 first-quarter net sales." It includes consolidated revenue figures, revenue breakdown by region, and commentary on product performance for that quarter. This structure perfectly matches the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only), rather than a comprehensive Interim Report (IR) or the full Annual Report (10-K). The document length is short, but it contains the results themselves, not just an announcement that results are available. Q1 2011
2011-04-27 English
Mise à disposition du Document de Référence 2010
Report Publication Announcement Classification · 99% confidence The document is a very short press release (1135 characters) dated April 20, 2011, titled "MISE A DISPOSITION DU DOCUMENT DE REFERENCE 2010" (Making available of the 2010 Reference Document). It explicitly states that the 'Document de Référence 2010' (which contains the annual financial report, management report, and governance information) has been filed with the AMF and is now available for consultation on the company website. According to Rule #2 (The 'MENU VS MEAL' Rule), a short announcement stating that a report has been published or is available elsewhere classifies this document as a Report Publication Announcement (RPA), not the full report itself (like 10-K or AR).
2011-04-20 French
Guerbet - Déclaration relative au nombre d'actions et de droits de vote au 31 Mars 2011
Regulatory Filings Classification · 95% confidence The document is titled "DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE" (Declaration relative to the number of voting rights and shares comprising the capital of the company). It explicitly references compliance with French commercial code (L. 233-8 II) and AMF regulations (article 222-12-5), requiring monthly publication of total voting rights and share capital if they have changed. The content is a table detailing the number of shares, treasury shares, theoretical voting rights, and exercisable voting rights as of March 31, 2011. This specific type of mandatory disclosure regarding the total number of voting rights is a distinct regulatory filing type. Among the provided definitions, this most closely aligns with a mandatory regulatory disclosure concerning share structure and voting rights, which fits best under 'Regulatory Filings' (RNS) as a general category, or potentially a specific type of capital/share announcement. However, since there is no specific code for 'Voting Rights Declaration', and it is a formal, periodic regulatory update, RNS is the most appropriate fallback, although it is a very specific type of filing. Given the content is a direct declaration of voting rights and capital structure, it is a core regulatory disclosure. If 'DVA' (Declaration of Voting Results & Voting Rights Announcements) is interpreted broadly to include periodic capital/voting rights declarations (not just post-meeting results), it could fit. However, DVA is defined as 'Official results from shareholder votes at any general meeting (AGM or EGM)'. Since this is a monthly capital structure update required by law, RNS (General regulatory announcements and fallback) is the safest classification, although it is a very specific regulatory filing. Let's re-evaluate the options. It is not an AGM result (DVA), not a share issue (SHA), and not a director's dealing (DIRS). It is a mandatory regulatory disclosure about the capital structure's voting power. RNS is the best fit for a mandatory, non-standard report type.
2011-04-07 French
Guerbet - Déclaration relative au nombre d'actions et de droits de vote au 28 Février 2011
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled "DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE" (Declaration relative to the number of voting rights and shares comprising the capital of the company). It explicitly references compliance with French commercial code (L. 233-8 II) and AMF (Autorité des Marchés Financiers) regulations, stating that the company publishes the total number of voting rights and shares monthly if they have changed. The content is a table detailing the total number of shares, treasury shares, theoretical voting rights, and exercisable voting rights as of February 28, 2011. This directly corresponds to the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA), which covers official results from shareholder votes or, in this context, mandatory periodic disclosures related to voting capital structure.
2011-03-18 French
Guerbet - Résultats annuels 2010
Earnings Release Classification · 95% confidence The document is titled 'COMMUNIQUE DE PRESSE' and presents 'Résultats annuels 2010' (Annual Results 2010) in a summary format, including key consolidated financial figures (Revenue, EBITDA, Net Income) for 2010 compared to 2009. It discusses product performance (Dotarem, Xenetix, Lipiodol) and mentions the upcoming Annual General Meeting (Assemblée Générale) where a dividend will be proposed. This structure—a press release summarizing full-year financial performance—is characteristic of an Earnings Release (ER). Although it covers the full year, it is presented as a high-level summary announcement rather than the comprehensive 10-K filing itself. The length (5259 chars) is substantial but the format is that of a summary release, not a full regulatory report. FY 2010
2011-03-02 French
Guerbet - 2010 Annual results
Earnings Release Classification · 98% confidence The document is titled '2010 Annual results' and presents consolidated financial data (€m) for the full year 2010 compared to 2009, including Net sales, EBITDA, Net income, and Net debt. It discusses performance drivers (Dotarem, Xenetix, Lipiodol) and future outlook, concluding with a mention of the upcoming General Meeting where a dividend will be proposed. This content structure—a detailed summary of full-year financial performance released to the public—is characteristic of an Earnings Release (ER) or the financial highlights section often preceding a full 10-K. Since it is a 'PRESS RELEASE' detailing the full year's results with key metrics and commentary, it fits the definition of an Earnings Release (ER) better than the comprehensive 10-K, which is a formal SEC filing. The document length (under 5,000 characters) also suggests it is a summary release rather than the full statutory report. FY 2010
2011-03-02 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.